GENETIC ANALYSIS OF REGULATION AND FUNCTION OF CD45
GENETIC ANALYSIS OF REGULATION AND FUNCTION OF CD45
批准号:
2837466
负责人:
WILLIAM C RASCHKE
金额:
$32.31万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 2002-11-30
中文摘要
白细胞共同抗原CD45已受到相当大的关注
最近,随着越来越多的证据表明它在信号转导中的作用,
在免疫反应中。 CD45具有以下有趣的性质:(a)
表达限于有核造血细胞,(B)多个
在细胞外结构域中不同的同种型,(c)严格
不同亚型在不同细胞中的调节表达
造血谱系,(d)具有蛋白质的大胞质结构域
酪氨酸磷酸酶(PTK)活性和(e)与
在细胞表面参与信号转导的复合物。 的CD45
分子似乎是一个重要的参与者的功能,
对细胞系的研究表明,CD45是
通过T和B上的细胞表面受体对最佳信号传导至关重要
淋巴细胞和可能的,通过外推,其他造血谱系
细胞 胞质结构域的PTB活性似乎是关键的,
信号功能。正在出现的模型是CD45功能
为了控制src家族蛋白酪氨酸的磷酸化状态
激酶,其成员已被证明在信号传导中发挥作用
通过T细胞受体和B细胞抗原受体。 校长
迄今为止的研究导致了我们目前对CD 45功能的概念
使用人工体外系统。 阻碍进展的主要问题
在回答关于CD45及其作用的进一步问题时,
从其cDNA表达CD45的能力。 即使成功,其他
不具有CD45的独特表达特征的启动子
必须被使用。 所提出的实验解决了以下功能:
CD45结构成分在体内通过引入突变到
完整的CD45基因 细胞外结构域,
胞质结构域和关键功能位点将在
这种方式。
英文摘要
The leukocyte common antigen CD45 has received considerable attention
recently as evidence accumulates for its role in signal transduction
during immune responses. CD45 has the interesting properties of (a)
expression restricted to nucleated hematopoietic cells, (b) multiple
isoforms which differ in the extracellular domain, (c) strictly
regulated expression of the different isoforms in the various
hematopoietic lineages, (d) a large cytoplasmic domain with protein
tyrosine phosphatase (PTPase) activity and (e) associations with
complexes at the cell surface involved in signal transduction. The CD45
molecule appears to be an important participant in the function of the
cells expressing it. Studies with cell lines have indicated CD45 is
essential for optimal signaling via cell surface receptors on T and B
lymphocytes and possibly, by extrapolation, other hematopoietic lineage
cells. The PTPase activity of the cytoplasmic domain appears critical
for the signaling function. The model that is emerging is CD45 functions
to control the state of phosphorylation of src family protein tyrosine
kinases, members of which have been shown to play roles in signaling
through the T cell receptor and B cell antigen receptor. The principal
studies to date that have led to our present concept of CD45 function
have used artificial in vitro systems. A major issue hindering progress
in answering further questions concerning CD45 and its role is the poor
ability to express CD45 from its cDNA. Even when successful, other
promoters not having the distinctive expression characteristics of CD45
have had to be used. The experiments proposed address the function of
CD45 structural components in vivo by introducing mutations into the
complete CD45 gene. The roles of the extracellular domain, the
cytoplasmic domain and critical functional sites will be evaluated in
this manner.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
siRNA Modulation of the Immune Response
-
批准号:8459220
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2013
-
负责人:WILLIAM C RASCHKE
-
依托单位:
siRNA Modulation of the Immune Response
-
批准号:8601289
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2013
-
负责人:WILLIAM C RASCHKE
-
依托单位:
A Novel Immune Modulator/ Adjuvant for HIV Vaccines
-
批准号:7555097
-
项目类别:
-
资助金额:$29.97万
-
财政年份:2008
-
负责人:WILLIAM C RASCHKE
-
依托单位:
A Novel Immune Modulator/ Adjuvant for HIV Vaccines
-
批准号:7651191
-
项目类别:
-
资助金额:$29.97万
-
财政年份:2008
-
负责人:WILLIAM C RASCHKE
-
依托单位:
Hemophilia A: Intrathymic Delivery for Tolerance and Longterm Expression of FVIII
-
批准号:7324891
-
项目类别:
-
资助金额:$14.99万
-
财政年份:2007
-
负责人:WILLIAM C RASCHKE
-
依托单位:
Non-Integrating FIV Vectors for HIV Vaccines
-
批准号:7270086
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2006
-
负责人:WILLIAM C RASCHKE
-
依托单位:
FIV Vectors for the Treatment of Hemophilia A
-
批准号:8239890
-
项目类别:
-
资助金额:$5.47万
-
财政年份:2005
-
负责人:WILLIAM C RASCHKE
-
依托单位:
FIV Vectors for the Treatment of Hemophilia A
-
批准号:7910804
-
项目类别:
-
资助金额:$90.58万
-
财政年份:2005
-
负责人:WILLIAM C RASCHKE
-
依托单位:
FIV Vectors for the Treatment of Hemophilia A
-
批准号:8268486
-
项目类别:
-
资助金额:$69.95万
-
财政年份:2005
-
负责人:WILLIAM C RASCHKE
-
依托单位:
FIV Vectors for the Treatment of Hemophilia A
-
批准号:8077953
-
项目类别:
-
资助金额:$100.94万
-
财政年份:2005
-
负责人:WILLIAM C RASCHKE
-
依托单位:
COMPLEMENTARY ADENOVIRAL VECTORS FOR TREATMENT OF CANCER
-
批准号:6335431
-
项目类别:
-
资助金额:$26.26万
-
财政年份:2000
-
负责人:WILLIAM C RASCHKE
-
依托单位:
MOLECULAR ANALYSIS RESOURCE FOR PRIMARY HUMAN CANCERS
-
批准号:6174295
-
项目类别:
-
资助金额:$33.58万
-
财政年份:1999
-
负责人:WILLIAM C RASCHKE
-
依托单位:
MOLECULAR ANALYSIS RESOURCE FOR PRIMARY HUMAN CANCERS
-
批准号:2903083
-
项目类别:
-
资助金额:$33.58万
-
财政年份:1999
-
负责人:WILLIAM C RASCHKE
-
依托单位:
A Mini-Ad Vector for Treatment of Factor VIII Deficiency
-
批准号:6527227
-
项目类别:
-
资助金额:$2.5万
-
财政年份:1999
-
负责人:WILLIAM C RASCHKE
-
依托单位:
MOLECULAR ANALYSIS RESOURCE FOR PRIMARY HUMAN CANCERS
-
批准号:6522316
-
项目类别:
-
资助金额:$34.72万
-
财政年份:1999
-
负责人:WILLIAM C RASCHKE
-
依托单位:
MOLECULAR ANALYSIS RESOURCE FOR PRIMARY HUMAN CANCERS
-
批准号:6377459
-
项目类别:
-
资助金额:$34.72万
-
财政年份:1999
-
负责人:WILLIAM C RASCHKE
-
依托单位:
A Mini-Ad Vector for Treatment of Factor VIII Deficiency
-
批准号:6404702
-
项目类别:
-
资助金额:$37.5万
-
财政年份:1999
-
负责人:WILLIAM C RASCHKE
-
依托单位:
MOLECULAR ANALYSIS RESOURCE FOR PRIMARY HUMAN CANCERS
-
批准号:6637095
-
项目类别:
-
资助金额:$34.72万
-
财政年份:1999
-
负责人:WILLIAM C RASCHKE
-
依托单位:
GENETIC ANALYSIS OF REGULATION AND FUNCTION OF CD45
-
批准号:6475709
-
项目类别:
-
资助金额:$35.65万
-
财政年份:1997
-
负责人:WILLIAM C RASCHKE
-
依托单位:
GENETIC ANALYSIS OF REGULATION AND FUNCTION OF CD45
-
批准号:6328742
-
项目类别:
-
资助金额:$35.74万
-
财政年份:1997
-
负责人:WILLIAM C RASCHKE
-
依托单位:
海外基金